Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MXCT MaxCyte > Detailed Quotes

MXCT MaxCyte

6.500
+0.220+3.50%
Close 09/30 16:00 ET
6.190
-0.310-4.77%
Post Mkt Price 09/30 16:19 ET
High
6.900
Open
6.150
Turnover
7.50M
Low
6.070
Pre Close
6.280
Volume
1.14M
Market Cap
661.21M
P/E(TTM)
Loss
52wk High
12.990
Shares
101.72M
P/E(Static)
Loss
52wk Low
3.360
Float Cap
582.44M
Bid/Ask %
-81.82%
Historical High
17.440
Shs Float
89.61M
Volume Ratio
1.82
Historical Low
3.360
Dividend TTM
--
Div Yield TTM
--
P/B
2.57
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.28%
Amplitude
13.22%
Avg Price
6.563
Lot Size
1
Float Cap
582.44M
Bid/Ask %
-81.82%
Historical High
17.440
Shs Float
89.61M
Volume Ratio
1.82
Historical Low
3.360
Dividend TTM
--
P/B
2.57
Dividend LFY
--
Turnover Ratio
1.28%
Amplitude
13.22%
Avg Price
6.563
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.
CEO: Mr. Douglas Arthur Doerfler
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...